Roche (OTCMKTS:RHHBY) Shares Unloaded Rep. Bruce Westerman

Representative Bruce Westerman (R-Arkansas) recently sold shares of Roche Holding AG (OTCMKTS:RHHBY). In a filing disclosed on May 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Roche stock on April 21st. The trade occurred in the Representative’s “FISHER IRA” account.

Representative Bruce Westerman also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of UniCredit (OTCMKTS:UNCRY) on 4/21/2025.
• Sold $1,001 – $15,000 in shares of CSX (NASDAQ:CSX) on 4/21/2025.
• Sold $1,001 – $15,000 in shares of Siemens Aktiengesellschaft (OTCMKTS:SIEGY) on 4/21/2025.
• Sold $1,001 – $15,000 in shares of GSK (NYSE:GSK) on 4/21/2025.
• Sold $1,001 – $15,000 in shares of Charles Schwab (NYSE:SCHW) on 4/21/2025.
• Sold $1,001 – $15,000 in shares of The Goldman Sachs Group (NYSE:GS) on 4/21/2025.
• Sold $1,001 – $15,000 in shares of Abbott Laboratories (NYSE:ABT) on 4/21/2025.
• Sold $1,001 – $15,000 in shares of Eli Lilly and Company (NYSE:LLY) on 4/21/2025.
• Sold $15,001 – $50,000 in shares of NVIDIA (NASDAQ:NVDA) on 4/21/2025.
• Sold $1,001 – $15,000 in shares of Chevron (NYSE:CVX) on 4/21/2025.

Roche Stock Down 2.6%

RHHBY opened at $38.34 on Wednesday. The stock’s fifty day moving average is $40.33 and its two-hundred day moving average is $38.62. Roche Holding AG has a 52 week low of $30.68 and a 52 week high of $44.31. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.97 and a current ratio of 1.26.

Analyst Ratings Changes

RHHBY has been the topic of several recent research reports. Sanford C. Bernstein raised Roche to a “strong-buy” rating in a research report on Thursday, January 30th. UBS Group raised Roche from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 13th. Morgan Stanley initiated coverage on Roche in a research report on Wednesday, February 12th. They set an “equal weight” rating on the stock. HSBC cut Roche from a “buy” rating to a “hold” rating in a research report on Monday, April 28th. Finally, Hsbc Global Res cut Roche from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 28th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating, one has given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold”.

Institutional Trading of Roche

A number of institutional investors have recently made changes to their positions in the business. GAMMA Investing LLC boosted its position in shares of Roche by 6,463.8% in the 1st quarter. GAMMA Investing LLC now owns 528,778 shares of the company’s stock worth $21,759,000 after purchasing an additional 520,722 shares in the last quarter. Boston Common Asset Management LLC lifted its position in Roche by 10.0% during the 1st quarter. Boston Common Asset Management LLC now owns 325,732 shares of the company’s stock worth $13,369,000 after acquiring an additional 29,522 shares during the period. Altrius Capital Management Inc increased its holdings in shares of Roche by 3.6% in the first quarter. Altrius Capital Management Inc now owns 189,993 shares of the company’s stock valued at $7,818,000 after purchasing an additional 6,545 shares during the period. Bard Financial Services Inc. boosted its position in Roche by 25.3% in the first quarter. Bard Financial Services Inc. now owns 138,900 shares of the company’s stock valued at $5,716,000 after buying an additional 28,050 shares during the last quarter. Finally, Rhumbline Advisers raised its position in Roche by 7.4% during the 1st quarter. Rhumbline Advisers now owns 107,252 shares of the company’s stock worth $4,413,000 after buying an additional 7,374 shares during the last quarter.

About Representative Westerman

Bruce Westerman (Republican Party) is a member of the U.S. House, representing Arkansas’ 4th Congressional District. He assumed office on January 3, 2015. His current term ends on January 3, 2027.

Westerman (Republican Party) is running for re-election to the U.S. House to represent Arkansas’ 4th Congressional District. He declared candidacy for the 2026 election.

Westerman earned his BSBAGE in biological and agricultural engineering from the University of Arkansas in 1990 and his MF in forestry from Yale University in 2001. His professional experience includes working as a plant engineer for Riceland Foods and an engineer/forester for Mid-South Engineering Company.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.